Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1356249

Fund Evaluation Group, LLC

Institutional asset managerFiled 2026-08-07 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$3.7B
Reported positions
80
Top holdings a year, 3 yrs
+17.0%
Assets under management
$23.9B

Fund Evaluation Group, LLC is an institutional asset manager that reported 80 positions worth $3.7B in its Q2 2026 13F, filed 2026-08-07. Its largest holdings were Ishares Tr (IVV, 29.5%), Schwab Strategic Tr (SCHG, 13.4%), Ishares Tr (GOVT, 11.3%). A portfolio copying its top holdings returned 17.0% a year over the last 3 years, against 22.3% for the S&P 500.

Fund Evaluation Group, LLC holdings largest 50 of 80 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Fund Evaluation Group, LLC 13F holdings
Stock% of 13F valueShare changeReported value
IVVIshares Tr29.5%-14.4%$1.1B
SCHGSchwab Strategic Tr13.4%+37.1%$495.7M
GOVTIshares Tr11.3%+2.4%$419.7M
SCHXSchwab Strategic Tr6.7%-9.4%$247.4M
IXUSIshares Tr5.5%-8.4%$203.8M
VOOVanguard Index Fds4.9%+26.1%$182.1M
SCHFSchwab Strategic Tr3.6%-13.1%$133.2M
VTIVanguard Index Fds3.0%+0.1%$109.7M
BSVVanguard Bd Index Fds2.5%—$92.3M
CATHGlobal X Fds2.3%+32.2%$86.4M
AGGIshares Tr1.3%+45.6%$47.3M
VOTETcw ETF Trust1.2%+18.6%$45.2M
SCHESchwab Strategic Tr1.1%-5.8%$41.8M
SHVIshares Tr0.8%+1.5%$31.1M
MLPXGlobal X Fds0.8%—$30.0M
VBVanguard Index Fds0.7%+198.6%$26.6M
RSPInvesco Exchange Traded Fd T0.7%+0.0%$25.5M
IGLBIshares Tr0.7%+71.2%$25.5M
VTHRVanguard Russell 3000 ETF0.7%-12.9%$25.2M
TLTIshares Tr0.6%+65.3%$22.9M
IWDIshares Tr0.6%+0.5%$22.9M
SPSMSpdr Series Trust0.6%-13.1%$21.6M
SCHPSchwab Strategic Tr0.5%+0.0%$19.8M
SCHOSchwab Strategic Tr0.5%+0.0%$18.7M
IWVIshares Tr0.5%-0.9%$18.0M
VEAVanguard Ftse Developed Markets Index Fu0.4%-0.2%$15.9M
SDYSpdr Ser Tr0.4%+0.0%$13.6M
IWOIshares Tr0.4%-4.2%$13.3M
IEFAIshares Tr0.4%—$13.3M
ESGDiShares ESG Aware MSCI EAFE ETF0.3%+3.0%$12.0M
SCHCSchwab Strategic Tr0.3%-3.7%$11.9M
DFUSDimensional ETF Trust0.3%+0.0%$11.5M
BIVVanguard Bd Index Fds0.3%+7.8%$11.1M
SUSAIshares Tr0.3%+1.4%$10.9M
VONVVanguard Scottsdale Fds0.3%+0.0%$10.2M
IEMGIshares Inc0.3%—$9.9M
BNDVanguard Bd Index Fds0.2%+0.0%$8.4M
EFAIshares Tr0.2%-14.1%$6.2M
STIPIshares Tr0.1%+18.6%$5.4M
BNDXVanguard Charlotte Fds0.1%—$5.4M
VSGXVanguard World Fd0.1%+1.6%$5.0M
DBCInvesco Db Commdy Indx Trck0.1%+0.0%$4.9M
VOVanguard Index Fds0.1%+300.0%$4.6M
IWRIshares Tr0.1%+0.0%$3.9M
EAGL2023 ETF Series Trust0.1%+0.0%$3.6M
IWFIshares Tr0.1%+513.8%$3.3M
DFIVDimensional ETF Trust0.1%-1.1%$3.1M
ACWIIshares Tr0.1%-2.3%$2.7M
VNQVanguard Index Fds0.1%—$2.6M
ACWXIshares Tr0.1%-1.2%$2.5M

What Fund Evaluation Group, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+7.6% /yr
S&P 500 +11.7%
3 years
+17.0% /yr
S&P 500 +22.3%
5 years
+7.3% /yr
S&P 500 +10.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$3.7B80
Q1 2026$3.3B73
Q4 2025$3.0B62
Q3 2025$2.8B75
Q2 2025$2.6B79
Q1 2025$2.3B48
Q4 2024$2.1B38
Q3 2024$1.8B33
Q2 2024$1.6B31
Q1 2024$1.6B38
Q4 2023$1.4B35
Q3 2023$1.1B33

Questions about Fund Evaluation Group, LLC's portfolio

What stocks does Fund Evaluation Group, LLC own?

Fund Evaluation Group, LLC's latest 13F, for Q2 2026 and filed Aug 7, 2026, lists 80 positions worth $3.7B. The largest are Ishares Tr (IVV) at 29.5%, Schwab Strategic Tr (SCHG) at 13.4%, Ishares Tr (GOVT) at 11.3%, Schwab Strategic Tr (SCHX) at 6.7% and Ishares Tr (IXUS) at 5.5%.

What did Fund Evaluation Group, LLC buy last quarter?

In Q2 2026, Fund Evaluation Group, LLC added Ishares Tr (IWF) (+513.8% shares), Vanguard Index Fds (VO) (+300.0% shares) and Vanguard Index Fds (VB) (+198.6% shares), compared with its Q1 2026 filing.

What did Fund Evaluation Group, LLC sell last quarter?

In Q2 2026, Fund Evaluation Group, LLC cut from its top 50 Vanguard Malvern Fds (VTIP), cut from its top 50 Ishares Tr (USRT), cut from its top 50 Gmo US Value ETF (GMOV), cut from its top 50 Spdr Index Shs Fds (SPGM), cut from its top 50 Ishares Tr (IWP), Ishares Tr (IVV) (-14.4% shares), Ishares Tr (EFA) (-14.1% shares) and Schwab Strategic Tr (SCHF) (-13.1% shares), compared with its Q1 2026 filing.

How has Fund Evaluation Group, LLC's portfolio performed?

A portfolio copying Fund Evaluation Group, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +17.0% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +7.6% against +11.7%. Over 5 years: +7.3% a year against +10.6%.

When is Fund Evaluation Group, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Fund Evaluation Group, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Fund Evaluation Group, LLC manage?

Fund Evaluation Group, LLC reported $23.9B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $3.7B.